Evidence method
Level · gp.fundamentals.capex_revenue_ratio
0.00% · OPTIONAL · VALID
GROSSPATTERN / FUNDAMENTAL STATE / POINT IN TIME
BFRI · Jun 30, 2026
Biofrontera Inc.. A multidimensional configuration derived from the filing available at this observation—never a composite score or recommendation.
STATE CAPABILITYLEVEL 3[email protected]
Inspectable configuration
State dimensions
Filing0001493152-26-037834General Corporate
Evidence method
Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
-13.81% · OPTIONAL · VALID
Evidence method
Yoy · gp.fundamentals.revenue
32.92% · CORE · VALID
Evidence method
Level · gp.fundamentals.inventory_revenue_ratio
9.14% · OPTIONAL · VALID
Evidence method
Level · gp.fundamentals.operating_margin
-4.37% · CORE · VALID
Evidence method
Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
3.73% · OPTIONAL · VALID
Evidence method
Level · gp.fundamentals.sbc_revenue_ratio
2.19% · OPTIONAL · VALID
As-filed lineage
Fundamental state history
Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History11 statesHistory building
Dec 31, 20230/7 normalizedLevel 3Mar 31, 20240/7 normalizedLevel 3Jun 30, 20240/7 normalizedLevel 3Sep 30, 20240/7 normalizedLevel 3Dec 31, 20244/7 normalizedLevel 3Mar 31, 20254/7 normalizedLevel 3Jun 30, 20255/7 normalizedLevel 3Sep 30, 20256/7 normalizedLevel 3Dec 31, 20257/7 normalizedLevel 3Mar 31, 20267/7 normalizedLevel 3Jun 30, 20267/7 normalizedLevel 3
Period transition
What moved in the state?
- Previous
- 0.05%
- Current
- 0.00%
- Delta
- -0.05%
- Previous
- -0.69%
- Current
- -13.81%
- Delta
- -13.12%
- Previous
- 17.42%
- Current
- 32.92%
- Delta
- 15.50%
- Previous
- 12.21%
- Current
- 9.14%
- Delta
- -3.07%
- Previous
- -42.84%
- Current
- -4.37%
- Delta
- 38.47%
- Previous
- 8.93%
- Current
- 3.73%
- Delta
- -5.19%
- Previous
- 3.39%
- Current
- 2.19%
- Delta
- -1.20%
Self-history only
Previous similar states
Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research
Compared To · Pharmaceutical Preparations peers →Has State · Biofrontera Inc. →Transitioned To · BFRI Fundamental State →Transitioned To · BFRI CAPEX_INTENSITY_DECREASED →Transitioned To · BFRI CASH_GENERATION_DECREASED →Transitioned To · BFRI GROWTH_INCREASED →Transitioned To · BFRI INVENTORY_PRESSURE_DECREASED →Transitioned To · BFRI PROFITABILITY_INCREASED →Transitioned To · BFRI R_AND_D_INTENSITY_DECREASED →Transitioned To · BFRI SBC_INTENSITY_DECREASED →
Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.